Ying Ming Wang
Directeur/Membre du Conseil chez NOVOPROTEIN SCIENTIFIC INC.
Profil
Ying Ming Wang is currently the Director at Novoprotein Scientific (Shanghai), Inc. since 2020.
Prior to this, Mr. Wang was the Director & Deputy General Manager at Suzhou Novoprotein Scientific Co., Ltd.
from 2009 to the present.
Mr. Wang graduated from Fudan University in 2014.
Postes actifs de Ying Ming Wang
| Sociétés | Poste | Début |
|---|---|---|
| NOVOPROTEIN SCIENTIFIC INC. | Directeur/Membre du Conseil | 01/02/2019 |
Novoprotein Scientific (Shanghai), Inc.
 Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu. | Directeur/Membre du Conseil | 12/08/2020 |
Formation de Ying Ming Wang
| Fudan University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NOVOPROTEIN SCIENTIFIC INC. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Novoprotein Scientific (Shanghai), Inc.
Novoprotein Scientific (Shanghai), Inc. Internet RetailRetail Trade Novoprotein Scientific (Shanghai), Inc. is a high-tech enterprise specializing in protein technology. Novoprotein Scientific (Shanghai is based in Shanghai, CN, with R&D and production bases in other locations, including Heze. The Chinese company's main focus is on biopharmaceuticals, in vitro diagnosis, vaccine drugs, and basic research on life sciences. The private company offers solutions such as targets and factor proteins, restructuring antibodies, enzymes, and reagents, and provide related technical services. The company was founded in 2009, and the CEO is Hua Xing Zhu. | Retail Trade |
